{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:58:29Z","timestamp":1789721909596,"version":"4.0.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.autrev.2012.07.024","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T05:22:14Z","timestamp":1343884934000},"page":"66-71","source":"Crossref","is-referenced-by-count":72,"title":["Gout as autoinflammatory disease: New mechanisms for more appropriated treatment targets"],"prefix":"10.1016","volume":"12","author":[{"given":"Leonardo","family":"Punzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Scanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ramonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2012.07.024_bb0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","article-title":"Pathogenesis of gout","volume":"143","author":"Choi","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2012.07.024_bb0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","article-title":"Gout","volume":"375","author":"Richette","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2012.07.024_bb0015","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","article-title":"Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study","volume":"372","author":"Dehghan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2012.07.024_bb0020","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/art.21242","article-title":"A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout","volume":"52","author":"Taniguchi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar3199","article-title":"Epidemiology of gout","volume":"12","author":"Roddy","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.07.024_bb0030","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0035","first-page":"1859","article-title":"Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China","volume":"35","author":"Miao","year":"2008","journal-title":"J Rheumatol"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2012.07.024_bb0040","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1093\/rheumatology\/kep086","article-title":"New insights into the epidemiology of gout","volume":"48","author":"Doherty","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2012.07.024_bb0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/387357a0","article-title":"Tyrannosaurs suffered from gout","volume":"387","author":"Rothschild","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.07.024_bb0050","first-page":"272","article-title":"Contributions of paleorheumatology to understanding contemporary disease","volume":"54","author":"Rothschild","year":"2002","journal-title":"Reumatismo"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2012.07.024_bb0055","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar1906","article-title":"A concise history of gout and hyperuricemia and their treatment","volume":"8","author":"Nuki","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.07.024_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4081\/reumatismo.2011.199","article-title":"Some historical remarks on microcrystalline arthritis (gout and chondrocalcinosis)","volume":"63","author":"Marson","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2012.07.024_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and alarmins: all we need to know about danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11926-011-0234-2","article-title":"Association between gout and all-cause as well as cardiovascular mortality: a systematic review","volume":"14","author":"Lottmann","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2012.07.024_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.autrev.2011.05.022","article-title":"Atherosclerosis in psoriatic arthritis","volume":"10","author":"Ramonda","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.024_bb0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.autrev.2006.12.003","article-title":"Pathogenetic and clinical rationale for TNF-blocking therapy in psoriatic arthritis","volume":"6","author":"Punzi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2012.07.024_bb0090","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.07.024_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4081\/reumatismo.2011.221","article-title":"Metabolism of crystals within the joint","volume":"63","author":"Oliviero","year":"2012","journal-title":"Reumatismo"},{"key":"10.1016\/j.autrev.2012.07.024_bb0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0046-8177(73)80013-9","article-title":"The synovitis of acute gouty arthritis. A light and electron microscopic study","volume":"4","author":"Agudelo","year":"1973","journal-title":"Hum Pathol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.1780050610","article-title":"The old and new concepts of acute gouty arthritis","volume":"5","author":"Seegmiller","year":"1962","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780120305","article-title":"Polymorphonuclear leukocyte motility in vitro. II. Stimulatory effect of monosodium urate crystals and urate in solution; partial inhibition by colchicine and indomethacin","volume":"12","author":"Phelps","year":"1969","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0115","first-page":"559","article-title":"Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1 beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis","volume":"78","author":"Matsukawa","year":"1998","journal-title":"Lab Invest"},{"key":"10.1016\/j.autrev.2012.07.024_bb0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0090-6980(84)90092-3","article-title":"Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate","volume":"27","author":"Serhan","year":"1984","journal-title":"Prostaglandins"},{"key":"10.1016\/j.autrev.2012.07.024_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.0603294","article-title":"Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8\/A9 from neutrophils","volume":"76","author":"Ryckman","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0130","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/rheumatology\/keh640","article-title":"Mechanisms of inflammation in gout","volume":"44","author":"Dalbeth","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2012.07.024_bb0135","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/annrheumdis-2011-200711","article-title":"Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor \u03b21 in the resolution phase","volume":"71","author":"Scanu","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.07.024_bb0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2249.2004.02563.x","article-title":"Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies","volume":"137","author":"McNearney","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.1780140411","article-title":"Sequential changes in human polymorphonuclear leukocytes after urate crystal phagocytosis","volume":"14","author":"Schumacher","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0150","first-page":"501","article-title":"Ultrastructural evidence for leakage of lysosomal contents after phagocytosis of monosodium urate crystals. A mechanism of gouty inflammation","volume":"76","author":"Shirahama","year":"1974","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/art.1780180213","article-title":"Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes","volume":"18","author":"Hoffstein","year":"1975","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0160","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.1780250504","article-title":"The role of cell surface proteins in platelet stimulation by monosodium urate crystals","volume":"25","author":"Jaques","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0165","first-page":"519","article-title":"Polymorphonuclear leukocyte responses to monosodium urate crystals: modification by adsorbed serum proteins","volume":"6","author":"Kozin","year":"1979","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0170","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar2930","article-title":"High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals","volume":"12","author":"Scanu","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.07.024_bb0175","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0006-291X(87)90417-7","article-title":"Monosodium urate and calcium pyrophosphate crystals differentially activate the excitation-response coupling sequence of human neutrophils","volume":"149","author":"Poubelle","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2012.07.024_bb0180","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.4049\/jimmunol.146.12.4289","article-title":"Mechanism of neutrophil activation by an unopsonized inflammatory particulate. Monosodium urate crystals induce pertussis toxin-insensitive hydrolysis of phosphatidylinositol 4,5-bisphosphate","volume":"146","author":"Onello","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1189\/jlb.70.4.659","article-title":"Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals","volume":"70","author":"Desaulniers","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-3-642-18805-3_6","article-title":"Roles of PI3K in neutrophil function","volume":"282","author":"Hannigan","year":"2004","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0195","first-page":"143","article-title":"Phagocytosis of sodium urate and calcium pyrophosphate crystals by leukocytes of gouty, pseudogouty and healthy donors","volume":"6","author":"de Medicis","year":"1983","journal-title":"Eur J Rheumatol Inflamm"},{"key":"10.1016\/j.autrev.2012.07.024_bb0200","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/art.23801","article-title":"Crystal-induced neutrophil activation: X. Proinflammatory role of the tyrosine kinase Tec","volume":"58","author":"Popa-Nita","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1096\/fasebj.12.2.209","article-title":"Crystal-induced neutrophil activation VI. Involvment of FcgammaRIIIB (CD16) and CD11b in response to inflammatory microcrystals","volume":"12","author":"Barab\u00e9","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2012.07.024_bb0210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.07.024_bb0215","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.174.8.5016","article-title":"TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation","volume":"174","author":"Liu-Bryan","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0220","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals","volume":"116","author":"Chen","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.07.024_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2012.07.024_bb0230","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.4049\/jimmunol.177.9.6370","article-title":"Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals","volume":"177","author":"Scott","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0235","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/art.27456","article-title":"Role of the leucine-rich repeat domain of cryopyrin\/NALP3 in monosodium urate crystal-induced inflammation in mice","volume":"62","author":"Hoffman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0240","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2012.07.024_bb0245","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.07.024_bb0250","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2007.082222","article-title":"Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process","volume":"68","author":"Giamarellos-Bourboulis","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.07.024_bb0255","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1\u03b2 production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0260","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1073\/pnas.0709684105","article-title":"ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way","volume":"105","author":"Piccini","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.07.024_bb0265","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1073\/pnas.0803933105","article-title":"The Nalp3 inflammasome is essential for the development of silicosis","volume":"105","author":"Cassel","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2012.07.024_bb0270","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","article-title":"Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases","volume":"117","author":"Martinon","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2012.07.024_bb0275","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0952-7915(00)00124-2","article-title":"TNFRSF1A mutations and autoinflammatory syndromes","volume":"12","author":"Galon","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0280","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2796.2010.02313.x","article-title":"Blocking interleukin-1\u03b2 in acute and chronic autoinflammatory diseases","volume":"269","author":"Dinarello","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2012.07.024_bb0285","doi-asserted-by":"crossref","first-page":"15662","DOI":"10.1016\/S0021-9258(18)66768-7","article-title":"Apolipoprotein B mediates the capacity of low density lipoprotein to suppress neutrophil stimulation by particulates","volume":"261","author":"Terkeltaub","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2012.07.024_bb0290","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1172\/JCI114971","article-title":"Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo","volume":"87","author":"Terkeltaub","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.07.024_bb0295","first-page":"809","article-title":"Calcium pyrophosphate and monosodium urate crystal interactions with neutrophils: effect of crystal size and lipoprotein binding to crystals","volume":"16","author":"Burt","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0300","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/art.10709","article-title":"Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals","volume":"48","author":"Akahoshi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0305","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/art.10468","article-title":"Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches","volume":"46","author":"Murakami","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0310","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","article-title":"Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis","volume":"46","author":"Getting","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0315","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/art.10614","article-title":"Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages","volume":"46","author":"Landis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0320","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/art.20317","article-title":"Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation","volume":"50","author":"Yagnik","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0325","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.1780390718","article-title":"Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1","volume":"39","author":"Liot\u00e9","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0330","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0163-7258(03)00035-4","article-title":"Genealogy, expression, and cellular function of transforming growth factor-beta","volume":"98","author":"Govinden","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.autrev.2012.07.024_bb0335","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.169.1.291","article-title":"Active and latent forms of transforming growth factor beta activity in synovial effusions","volume":"169","author":"Fava","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2012.07.024_bb0340","first-page":"420","article-title":"Transforming growth factor-beta levels in synovial fluid of osteoarthritis with or without calcium pyrophosphate dihydrate crystals","volume":"30","author":"Punzi","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0345","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6 Suppl. 1","key":"10.1016\/j.autrev.2012.07.024_bb0350","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3810\/pgm.2011.11.2511","article-title":"Recommendations for the diagnosis and management of gout and hyperuricemia","volume":"123","author":"Hamburger","year":"2011","journal-title":"Postgrad Med"},{"issue":"9","key":"10.1016\/j.autrev.2012.07.024_bb0355","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","article-title":"Patient and provider barriers to effective management of gout in general practice: A qualitative study","volume":"71","author":"Spencer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2012.07.024_bb0360","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.27635","article-title":"Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer?","volume":"62","author":"Neogi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0365","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0370","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2012.07.024_bb0375","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1749-6632.2009.04674.x","article-title":"Colchicine revisited","volume":"1173","author":"Bhat","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.07.024_bb0380","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","article-title":"The role of interleukin-1 and the inflammasome in gout: implications for therapy","volume":"56","author":"Pope","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.07.024_bb0385","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","article-title":"Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action","volume":"163","author":"Marques-da-Silva","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0390","unstructured":"E. Pascual, F. Sivera. Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment."},{"key":"10.1016\/j.autrev.2012.07.024_bb0395","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10067-010-1457-8","article-title":"International position paper on febuxostat","volume":"29","author":"Tim","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0400","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jbspin.2012.01.004","article-title":"Therapeutic perspectives on uricases for gout","volume":"79","author":"Garay","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2012.07.024_bb0405","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/BOR.0b013e32834ff637","article-title":"Up-to-date management of gout","volume":"24","author":"Jordan","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2012.07.024_bb0410","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/hcr242","article-title":"Recent advances in management of gout","volume":"105","author":"Suresh","year":"2011","journal-title":"QJM"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T02:34:44Z","timestamp":1714271684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1568997212001607"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.07.024","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}